Overview This page contains the latest trade data of Glands and Other Organs. In 2022, Glands and Other Organs were the world's 520th most traded product, with a total trade of $5.83B. Between 2021 and 2022 the exports of Glands and Other Organs decreased by -5.7%, from $6.18B to $5.83B. Trade in Glands and Other Organs represent 0.025% of total world trade.
Glands and Other Organs are a part of Pharmaceutical products. They include Heparin, salts, for therapeutic use, Extracts of glands etc. for therapeutic use, and Glands and other organs, dried, for therapeutic uses.
Exports In 2022 the top exporters of Glands and Other Organs were China ($1.29B), United States ($831M), France ($756M), Singapore ($716M), and Spain ($398M).
Imports In 2022 the top importers of Glands and Other Organs were France ($1.11B), Singapore ($672M), United States ($451M), Spain ($324M), and China ($282M).
Ranking Glands and Other Organs ranks 342nd in the Product Complexity Index (PCI).
Description Dried glands and other organs for organo-therapeutic uses are used for their supposed medicinal properties. Extracts of glands or other organs or their secretions, for organo-therapeutic uses, are used to treat many ailments. Heparin and its salts are used to prevent blood clots. Other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified, are used to treat many ailments.